Glass Wealth Management’s Pfizer PFE Stock Holding History

Glass Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Buy	100,166 +7,850	+9%	+$205K	0.81%	34
2026 Q1	$2.59M	Buy	92,316 +2,835	+3%	+$75.5K	1%	31
2025 Q4	$2.23M	Buy	89,481 +989	+1%	+$24.9K	0.91%	34
2025 Q3	$2.25M	Buy	88,492 +3,145	+4%	+$77.6K	1.01%	32
2025 Q2	$2.07M	Sell	85,347 -1,919	-2%	-$44.8K	1.1%	33
2025 Q1	$2.21M	Sell	87,266 -17,129	-16%	-$448K	1.33%	27
2024 Q4	$2.77M	Buy	104,395 +709	+0.7%	+$19.2K	1.51%	23
2024 Q3	$3M	Buy	103,686 +3,116	+3%	+$90.9K	1.66%	21
2024 Q2	$2.81M	Buy	100,570 +1,474	+1%	+$40.6K	1.65%	26
2024 Q1	$2.75M	Buy	+99,096	New	+$2.75M	1.68%	25

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Glass Wealth Management's PFE Position: Q2 2026 in Review

Glass Wealth Management increased its Pfizer (PFE) stake by 8.5% in Q2 2026, buying an estimated $205K and bringing the position to 100,166 shares worth $2.41M. The position accounts for 0.81% of the portfolio, ranked #34.

Glass Wealth Management first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $3M in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Glass Wealth Management held 100,166 shares of Pfizer worth $2.41M as of Q2 2026.
Glass Wealth Management bought 7,850 Pfizer shares in Q2 2026, an estimated $205K.
Pfizer made up 0.81% of Glass Wealth Management's portfolio in Q2 2026, its #34 holding.
Glass Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
Glass Wealth Management's Pfizer position peaked at $3M in Q3 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Glass Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.